Correction to ‘Dose escalation of biologic treatment in patients with moderate-to-severe psoriasis in Japan’

IF 3.5 3区医学 Q1 DERMATOLOGY

Experimental Dermatology Pub Date : 2024-07-16 DOI:10.1111/exd.15139

引用次数: 0

Abstract

Tada Y, Soliman AM, Ishii K, Sakuma R, Pinter A, Davis M, Nunag D, Buessing M, Puig L, Imafuku S. Dose escalation of biologic treatment in patients with moderate-to-severe psoriasis in Japan. Exp Dermatol. 2024 May;33(5):e15067. doi: 10.1111/exd.15067. PMID: 38757460.

https://onlinelibrary.wiley.com/doi/10.1111/exd.15067

In addition, also in Experimental Design, ‘gusekumab’ is misspelled and should be ‘guselkumab’.

We apologize for this error; however, note that it has no impact on the results of the study and the findings are unchanged.

查看原文本刊更多论文

日本中重度银屑病患者生物制剂治疗剂量升级 "的更正。

Tada Y、Soliman AM、Ishii K、Sakuma R、Pinter A、Davis M、Nunag D、Buessing M、Puig L、Imafuku S.日本中重度银屑病患者生物制剂治疗的剂量升级。Exp Dermatol.2024 May;33(5):e15067.DOI: 10.1111/EXD.15067.PMID: 38757460. https://onlinelibrary.wiley.com/doi/10.1111/exd.15067 此外，在 "实验设计 "中，"gusekumab "拼写错误，应为 "guselkumab"。我们对此错误表示歉意；但请注意，这对研究结果没有影响，研究结果保持不变。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Experimental Dermatology 医学-皮肤病学

CiteScore

6.70

自引率

5.60%

发文量

201

审稿时长

2 months

期刊介绍： Experimental Dermatology provides a vehicle for the rapid publication of innovative and definitive reports, letters to the editor and review articles covering all aspects of experimental dermatology. Preference is given to papers of immediate importance to other investigators, either by virtue of their new methodology, experimental data or new ideas. The essential criteria for publication are clarity, experimental soundness and novelty. Letters to the editor related to published reports may also be accepted, provided that they are short and scientifically relevant to the reports mentioned, in order to provide a continuing forum for discussion. Review articles represent a state-of-the-art overview and are invited by the editors.